Home › NDC Lookup › RxCUI directory › RxCUI 996179

Vardenafil 10 MG Disintegrating Oral Tablet — RxCUI 996179

RxNorm drug concept · Semantic clinical drug
RxCUI 996179 Semantic clinical drug · SCD ● Current RxNorm concept 3 FDA products 3 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI996179
Official nameVardenafil 10 MG Disintegrating Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asvardenafil 10 MG (vardenafil HCl 11.85 MG) Disintegrating Oral Tablet
FDA products mapped3
Package NDCs mapped3
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Vardenafil: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Generally, you should take vardenafil about 60 minutes before sexual activity — that's when it tends to work best. For the standard tablet, food doesn't really matter; you can take...
  • How long before sex should I take vardenafil, and does it matter if I eat first?
  • This is really important to go over with your doctor. If you take any nitrate medications — like nitroglycerin for chest pain — you absolutely cannot take vardenafil. The combinati...
  • Can I take vardenafil with my other heart or blood pressure medications?
📖 Read our full Vardenafil guide →

🕸️ Concept Web — How Vardenafil 10 MG Disintegrating Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Vardenafil 10 MG Disintegrating Oral Tablet RxCUI 996179

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Vardenafil 306674
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Staxyn 996180
  3. Dose forms 12

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Vardenafil Disintegrating Oral Tablet 996178
    • Vardenafil Disintegrating Oral Product 1295003
    • Vardenafil Oral Product 1164565
    • Vardenafil Pill 1164566
    • Vardenafil Disintegrating Oral Tablet [Staxyn] 996182
    • Staxyn Disintegrating Oral Product 1296842
    • Staxyn Oral Product 1178426
    • Staxyn Pill 1178429
    • +4 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Vardenafil 10 MG 358798
    • Vardenafil 10 MG Disintegrating Oral Tablet [Staxyn] 996183
    • Vardenafil 10 MG [Staxyn] 996181

Showing up to 8 concepts per family — 13 of 17 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Vardenafil 10 MG SCDC · 358798
  • Vardenafil Disintegrating Oral Tablet SCDF · 996178
  • Vardenafil Disintegrating Oral Product SCDG · 1295003
  • Vardenafil Oral Product SCDG · 1164565
  • Vardenafil Pill SCDG · 1164566

Brand-Name Concepts

  • Vardenafil 10 MG Disintegrating Oral Tablet [Staxyn] SBD · 996183
  • Vardenafil 10 MG [Staxyn] SBDC · 996181
  • Vardenafil Disintegrating Oral Tablet [Staxyn] SBDF · 996182
  • Staxyn Disintegrating Oral Product SBDG · 1296842
  • Staxyn Oral Product SBDG · 1178426
  • Staxyn Pill SBDG · 1178429
  • Staxyn BN · 996180

📦 FDA Products & Package NDCs

3 products · 3 package NDCs
3 package NDCs map to RxCUI 996179 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
33342-0203-37 1 BLISTER PACK in 1 CARTON (33342-203-37) / 4 TABLET in 1 B... Vardenafil Macleods Pharmaceuticals Limited 2018-10-26
46708-0235-04 4 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (46708-235... Vardenafil Alembic Pharmaceuticals Limited 2018-11-20
62332-0235-04 4 BLISTER PACK in 1 CARTON (62332-235-04) / 4 TABLET, ORALL... Vardenafil Alembic Pharmaceuticals Inc. 2018-11-20
Observed labelers: Alembic Pharmaceuticals Inc. (1) · Alembic Pharmaceuticals Limited (1) · Macleods Pharmaceuticals Limited (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.